Manufacturer record
Wamika Pharmaceuticals Private Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Wamika Pharmaceuticals Private Limited (Haryana) were declared Not of Standard Quality between September 2022 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L25078, Cyproheptadine, Tricholine and Sorbitol oral solution Cypliv (exp Jul 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Sorbitol (70%). Listed in the December 2025 alert.
Records by type
3 records linked to Wamika Pharmaceuticals Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cyproheptadine, Tricholine and Sorbitol oral solution Cypliv | Batch L25078Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Sorbitol (70%).Assay | RDTL, ChandigarhCDSCO lab | Dec 2025 |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup Wamicof-AX Expectorant | Batch L25082Mfg Sep 2025 · Exp Aug 2027 | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Terbutaline SulphateAssay | RDTL, ChandigarhCDSCO lab | Dec 2025 |
| Pantoprazole Sodium Gastro Resistant Tablets I.P. Pantofer-40 Tablets | Batch T 21351Mfg Dec 2021 · Exp Nov 2023 | Dissolution (Buffer Stage)Dissolution | RDTL GuwahatiState lab | Sep 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.